Presbycusis

H8_HL_PRESBY

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H91.1 Hospital discharge: ICD-9 — 3880 Hospital discharge: excluded ICD-9 — 2880X Cause of death: ICD-10 — H91.1 Cause of death: ICD-9 — 3880 Cause of death: excluded ICD-9 — 2880X 2 out of 7 registries used, show all original rules.	5981
4. Check minimum number of events None	5981
5. Include endpoints None	5981
6. Filter based on genotype QC (FinnGen only)	5981

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H91
Name in latin: Presbyacusis

NAME	H8_HL_PRESBY
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H911
HD_ICD_9	3880
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	2880X
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H911
COD_ICD_9	3880
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	2880X
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Presbycusis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64425	38004	26033
Only index persons	55412	33250	22162
Unadjusted period prevalence (%)
Whole population	0.94	1.09	0.73
Only index persons	1.07	1.22	0.85
Median age at first event (years)
Whole population	80.01	81.05	78.51
Only index persons	79.56	80.63	77.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5981	2765	3216
Unadjusted period prevalence (%)	1.20	0.94	1.42
Median age at first event (years)	76.72	76.80	76.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5284: Matched controls
52556

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02

ICPC

Hearing complaint

7.3

323.0

1504

2724

DFF15

NOMESCO Finland

Speech audiometry

20.6

323.0

565

303

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

5.8

323.0

1134

2354

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

71.4

323.0

785

128

H91.1

ICD-10 Finland

Presbycusis

4503599627370496.0

323.0

5280

907

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

4.0

323.0

1933

6648

SPAT1043

SPAT

Audiometry

7.8

323.0

1291

2102

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

30.8

323.0

604

219

UDC00

NOMESCO Finland

Ear microscopy

13.2

323.0

900

806

R5120

NOMESCO Finland

Preparation of an aid

20.0

323.0

504

275

Z01.1

ICD-10 Finland

Examination of ears and hearing

15.0

323.0

1854

1830

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

32.9

323.0

1432

587

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

203.1

323.0

2522

235

DAX08

NOMESCO Finland

Fitting of hearing aid

33.6

323.0

701

238

Z97.4

ICD-10 Finland

Presence of external hearing-aid

35.9

323.0

1142

400

DFF00

NOMESCO Finland

Pure tone audiometry

20.9

323.0

1085

641

H13

ICPC

Plugged feeling ear

3.6

279.6

1580

5609

Z3229

NOMESCO Finland

Other healthcare associate professional

5.3

272.1

922

2007

R5140

NOMESCO Finland

Monitoring the use of the aid

5.5

251.9

822

1703

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

21.4

241.3

364

181

H91.9

ICD-10 Finland

Hearing loss, unspecified

11.7

238.9

461

424

H84

ICPC

Presbyacusis

7.3

195.8

503

751

H81

ICPC

Excessive ear wax

3.0

192.8

1356

5411

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

9.3

172.0

375

429

R4135

NOMESCO Finland

Rehabilitation for hearing problems

39.0

164.8

211

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.5

158.0

610

1475

H93.1

ICD-10 Finland

Tinnitus

10.6

144.6

291

286

A98

ICPC

Health maint/preventive medicine

2.4

144.4

4359

34654

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

130.5

142.6

153

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

82.1

141.8

160

N02BE01

ATC

paracetamol; systemic, rectal

2.4

137.0

4439

35882

H29

ICPC

Ear symptom/complaint other

3.5

134.7

714

2266

TDA90

NOMESCO Finland

Removal wax from ear

16.1

123.6

205

131

SPAT1263

SPAT

Sampling

2.0

121.9

2270

14214

SPAT1310

SPAT

Counselling related to known health issue

2.1

115.4

1704

9635

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.0

109.2

2249

14446

SPAT1301

SPAT

No procedures

1.9

92.5

1868

11703

R5599

NOMESCO Finland

Other rehabilitation service

5.9

91.6

268

468

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

80.4

91.2

103

J01DB01

ATC

cefalexin; oral

1.9

88.7

3785

30290

SPAT1312

SPAT

General health counselling

2.0

87.7

1510

8874

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

87.6

2705

19447

SPAT1325

SPAT

Vaccination

1.8

86.3

2130

14211

SPAT1153

SPAT

Removal of sutures

1.9

85.6

1689

10420

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

82.4

2365

16486

SPAT1260

SPAT

Consultation of another employee

2.2

81.8

1034

5332

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

81.1

1916

12523

Z97.8

ICD-10 Finland

Presence of other specified devices

83.7

81.1

N07CA01

ATC

betahistine; oral

3.0

78.4

493

1734

R1260

NOMESCO Finland

Evaluation of communicative skills

6.4

75.8

208

334

SPAT1097

SPAT

Recording of ECG

2.1

74.3

974

5080

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

8.2

73.6

170

212

-44

ICPC

Preventive immunization/medic

2.5

73.4

666

2914

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

71.6

1523

9518

-1

NOMESCO Finland

1.9

70.9

1219

7062

SPAT1053

SPAT

Memory test

1.9

70.0

1279

7568

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

68.0

2278

16304

A02BC02

ATC

pantoprazole; systemic

1.7

66.9

3220

25445

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

46.8

64.5

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

136.9

63.9

H61.2

ICD-10 Finland

Impacted cerumen

3.1

62.8

380

1298

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

62.2

1232

7448

ZXA10

NOMESCO Finland

Bilateral

1.8

60.9

1190

7156

WX110

NOMESCO Finland

Local anesthesy

1.6

60.0

2651

20194

S18

ICPC

Laceration/cut

1.6

59.7

2053

14632

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

59.4

1622

10825

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

58.7

2267

16637

N40

ICD-10 Finland

Hyperplasia of prostate

1.7

55.4

1507

10001

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

54.8

1015

5964

P20

ICPC

Memory disturbance

1.8

53.9

1037

6168

SPAT1262

SPAT

Handing over of treatment supplies

1.8

53.1

1042

6235

RK520

NOMESCO Finland

27.2

52.9

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

15.1

52.3

H28

ICPC

Limited function/disability (H)

9.0

52.2

113

127

AA1AD

NOMESCO Finland

CT of head and brain

1.7

51.6

1444

9621

R01AD09

ATC

mometasone; nasal

1.7

51.3

1520

10290

J01CA04

ATC

amoxicillin; systemic

1.6

51.2

3427

28399

R42

ICD-10 Finland

Dizziness and giddiness

1.7

50.8

1306

8483

SPAT1304

SPAT

Counselling and guidance related to ageing

2.1

50.2

631

3188

R05

ICPC

Cough

1.8

50.0

959

5677

H04

ICPC

Ear discharge

3.7

47.7

220

612

R01AD12

ATC

fluticasone furoate; nasal

1.9

45.1

800

4597

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

44.8

1595

11241

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

44.4

2366

18327

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

45.1

44.0

G04CA02

ATC

tamsulosin; oral

1.6

43.9

1578

11138

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

41.8

3472

29432

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.9

40.3

264

947

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

40.1

2038

15502

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.3

39.8

414

1911

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

39.6

1055

6848

R02

ICPC

Shortness of breath/dyspnoea

1.9

39.6

668

3759

M79.6

ICD-10 Finland

Pain in limb

1.5

39.2

1524

10897

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

25.1

39.1

SPAT1131

SPAT

Colonoscopy

3.0

38.9

232

784

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

38.7

2235

17427

U04

ICPC

Incontinence urine

2.4

38.3

358

1570

Z01.9

ICD-10 Finland

Special examination, unspecified

2.5

38.3

312

1274

XKD00

NOMESCO Finland

Uroflowmetry

1.7

38.3

1014

6563

M01AH05

ATC

etoricoxib; oral

1.5

38.2

2025

15494

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

37.9

984

6334

M54.5

ICD-10 Finland

Low back pain

1.6

37.8

1280

8832

H01

ICPC

Ear pain/earache

2.3

37.7

357

1578

L08

ICPC

Shoulder symptom/complaint

1.7

37.6

825

5053

ZXE00

NOMESCO Finland

One hour or less

1.5

37.4

1908

14459

-69

ICPC

Other reason for encounter NEC

2.7

37.1

274

1059

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

36.9

1379

9736

ZXC50

NOMESCO Finland

Cryotherapy

2.7

36.2

267

1030

N17

ICPC

Vertigo/dizziness

1.8

35.8

631

3598

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

35.3

1019

6735

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

35.2

672

3932

L03

ICPC

Low back symptom/complaint

1.6

35.1

971

6343

RK320

NOMESCO Finland

7.2

35.0

120

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

34.7

675

3973

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

34.2

1321

9372

L13

ICPC

Hip symptom/complaint

1.7

34.0

813

5095

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

33.9

3584

31125

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.0

33.1

199

676

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

33.1

1285

9115

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

32.7

338

1554

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

32.7

1837

14092

RK420

NOMESCO Finland

170.1

32.7

C07AB07

ATC

bisoprolol; oral

1.4

32.6

2857

23842

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

12.1

32.2

R06.0

ICD-10 Finland

Dyspnoea

1.5

32.2

1347

9705

M03BX02

ATC

tizanidine; oral

1.4

32.0

2014

15779

-31

ICPC

Medical examin/health eval partial

2.1

31.9

408

2059

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

31.9

1730

13163

R03AC02

ATC

salbutamol; inhalant

1.4

31.4

2109

16704

L12

ICPC

Hand/finger symptom/complaint

1.8

31.4

558

3180

A28

ICPC

Limited function/disability NOS

1.5

31.3

1160

8123

KMAK

NOMESCO Finland

1.5

31.2

1661

12576

UKC02

NOMESCO Finland

Cystoscopy

1.6

30.4

1016

6931

G47.3

ICD-10 Finland

Sleep apnoea

1.7

29.9

677

4166

L17

ICPC

Foot/toe symptom/complaint

1.5

29.6

1120

7865

RK110

NOMESCO Finland

6.3

29.6

128

S82

ICPC

Naevus/mole

1.9

29.6

490

2725

J01AA02

ATC

doxycycline; systemic

1.4

29.4

3542

31013

H26.4

ICD-10 Finland

After-cataract

1.7

29.4

730

4607

HMAK

NOMESCO Finland

2.0

29.0

415

2189

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

29.0

1771

13724

G04BD12

ATC

mirabegron; oral

1.8

28.6

582

3464

SPAT1211

SPAT

Application of soft bandage

1.9

28.6

471

2612

C10AA01

ATC

simvastatin; oral

1.4

28.5

2704

22634

H92.0

ICD-10 Finland

Otalgia

3.2

28.5

152

476

L01

ICPC

Neck symptom/complaint

1.8

28.4

506

2885

H81.0

ICD-10 Finland

Ménière disease

4.1

28.3

112

274

D07AC01

ATC

betamethasone; topical

1.4

28.1

1479

11118

HAHOM

NOMESCO Finland

6.8

27.9

105

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

27.6

870

5838

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

27.5

748

4831

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

9.1

27.5

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.8

27.4

465

2609

U02

ICPC

Urinary frequency/urgency

1.7

27.3

619

3799

SPAT1377

SPAT

Polysomnography

3.5

27.3

133

389

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

26.8

1204

8750

L15

ICPC

Knee symptom/complaint

1.6

26.8

864

5829

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

26.7

670

4232

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.7

26.6

565

3401

H02AB06

ATC

prednisolone; systemic

1.4

26.1

2159

17563

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.6

25.9

785

5212

A02BC05

ATC

esomeprazole; systemic

1.4

25.8

1725

13510

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.6

25.7

194

760

SPAT1041

SPAT

Comprehensive hearing test

5.3

25.4

151

SPAT1058

SPAT

PEF monitoring instruction

2.0

25.4

359

1883

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

25.2

1352

10160

H80.9

ICD-10 Finland

Otosclerosis, unspecified

10.9

25.2

M01AX05

ATC

glucosamine; oral

1.5

25.1

1181

8646

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

24.9

1783

14117

-51

ICPC

I&d/flush/aspiration

4.0

24.7

100

251

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

24.5

1726

13612

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

24.3

1381

10480

SPAT1252

SPAT

Overall medication plan or its review

1.8

24.1

446

2571

K02.1

ICD-10 Finland

Caries of dentine

1.4

24.1

1691

13319

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

24.0

1400

10670

M25.5

ICD-10 Finland

Pain in joint

1.5

24.0

921

6452

J01FA10

ATC

azithromycin; systemic

1.4

23.9

1811

14448

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

23.8

1656

13016

G04CA01

ATC

alfuzosin; oral

1.6

23.8

630

4030

M01AB05

ATC

diclofenac; systemic, rectal

1.3

23.8

2583

21827

D82

ICPC

Teeth/gum disease

1.5

23.8

932

6557

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

23.7

1106

8074

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

23.5

775

5238

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

23.4

436

2514

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

23.4

451

2631

R21

ICPC

Throat symptom/complaint

1.8

23.4

463

2724

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

23.3

450

2628

TDA90

SPAT

3.3

23.2

122

379

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

23.2

479

2855

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.7

23.2

172

XCH00

NOMESCO Finland

Eye pressure measurement

2.2

23.1

242

1121

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

23.0

750

5056

RD211

NOMESCO Finland

2.3

23.0

216

950

RK120

NOMESCO Finland

13.9

22.9

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

22.6

1488

11560

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

10.0

22.6

S29

ICPC

Skin symptom/complaint other

1.6

22.5

732

4931

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

22.4

1011

7312

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

22.3

1656

13124

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

22.3

524

3246

L57.0

ICD-10 Finland

Actinic keratosis

1.6

22.2

652

4282

A02BC01

ATC

omeprazole; systemic

1.4

22.0

1459

11337

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

22.0

576

3671

C10AA05

ATC

atorvastatin; oral

1.3

22.0

1990

16275

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.3

21.9

201

876

S21

ICPC

Skin texture symptom/complaint

1.6

21.8

557

3530

A04

ICPC

Weakness/tiredness general

1.6

21.7

685

4579

R01AD01

ATC

beclometasone; nasal

1.6

21.7

545

3433

N03AX12

ATC

gabapentin; oral

1.6

21.7

627

4101

R05

ICD-10 Finland

Cough

1.5

21.6

780

5377

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

21.6

457

2745

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

21.5

879

6223

P06

ICPC

Sleep disturbance

1.9

21.5

316

1682

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

20.7

21.1

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

21.4

20.7

Z02.4

ICD-10 Finland

Examination for driving licence

1.4

20.6

1232

9382

E0000UV

ATC

1.4

20.6

1582

12571

A02BC03

ATC

lansoprazole; oral

1.4

20.6

1410

10997

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

20.5

731

5023

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

20.5

1630

13024

R06AE07

ATC

cetirizine; oral

1.4

20.5

1502

11845

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

20.1

1710

13799

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

20.1

620

4117

R53

ICD-10 Finland

Malaise and fatigue

1.4

19.9

1097

8228

UJF32

NOMESCO Finland

Coloscopy

1.4

19.8

1222

9345

G04BD08

ATC

solifenacin; oral

1.7

19.7

399

2360

C08CA01

ATC

amlodipine; oral

1.3

19.7

2032

16867

B01AF02

ATC

apixaban; oral

1.6

19.6

611

4066

R74

ICPC

Upper respiratory infection acute

1.6

19.6

613

4081

J01MA02

ATC

ciprofloxacin; systemic

1.3

19.5

1934

15952

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.9

19.3

122

431

Z00.0

ICD-10 Finland

General medical examination

1.5

19.3

792

5606

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.7

19.2

138

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.7

19.2

436

2669

K86

ICPC

Hypertension uncomplicated

1.5

19.2

626

4209

207

Kela drug reimbursment

Chronic arrhythmias

1.4

19.2

1003

7444

R01AD08

ATC

fluticasone; nasal

1.4

19.1

870

6286

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

7.2

19.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

19.1

515

3303

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

19.1

648

4399

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.1

18.9

208

984

G04CB02

ATC

dutasteride; oral

1.7

18.7

390

2328

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

18.7

1272

9877

G44.2

ICD-10 Finland

Tension-type headache

1.7

18.7

411

2495

L16

ICPC

Ankle symptom/complaint

1.7

18.6

372

2191

H60.8

ICD-10 Finland

Other otitis externa

3.1

18.6

103

335

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

5.3

18.6

105

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.6

18.5

138

538

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

18.5

2505

21529

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

18.4

470

2972

K80

ICPC

Cardiac arrhythmia NOS

1.8

18.3

341

1967

H83.3

ICD-10 Finland

Noise effects on inner ear

6.3

18.2

WX723

NOMESCO Finland

CPAP therapy

3.0

18.1

105

352

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

18.1

850

6173

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

18.1

216

1061

B01AC04

ATC

clopidogrel; oral

1.4

18.1

989

7393

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

17.8

1633

13264

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.7

17.7

128

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

17.7

C09CA01

ATC

losartan; oral

1.4

17.6

1197

9284

K30

ICD-10 Finland

Functional dyspepsia

1.7

17.5

378

2281

L14

ICPC

Leg/thigh symptom/complaint

1.7

17.4

354

2097

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

15.5

17.4

C09AA05

ATC

ramipril; oral

1.3

17.3

1484

11932

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

16.9

435

2757

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

16.8

343

2038

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

16.7

1008

7655

H91

ICD-10 Finland

Other hearing loss

4.8

16.6

115

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

16.6

949

7135

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

16.6

1150

8934

A03

ICPC

Fever

1.7

16.5

393

2435

WX720

NOMESCO Finland

Own respiration

2.3

16.5

153

672

B01AB05

ATC

enoxaparin; parenteral

1.3

16.4

1410

11319

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

16.3

1097

8477

R51.80

ICD-10 Finland

Headache

1.6

16.3

427

2717

H91.8

ICD-10 Finland

Other specified hearing loss

6.0

16.2

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

16.2

640

4485

WX320

NOMESCO Finland

Spinalanesthesy

1.4

16.1

1023

7828

SPAT1254

SPAT

Administration of medicine

1.4

16.1

798

5844

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

16.0

215

1109

A97

ICPC

No disease

1.5

15.8

620

4332

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

15.8

146

641

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

15.7

423

2712

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

15.7

1741

14469

M01AC06

ATC

meloxicam; systemic, rectal

1.3

15.7

1406

11341

K85

ICPC

Elevated blood pressure

1.4

15.6

775

5671

Z71.8

ICD-10 Finland

Other specified counselling

1.4

15.6

811

5989

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.1

15.5

174

832

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

15.5

506

3395

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

15.4

423

2724

H60.3

ICD-10 Finland

Other infective otitis externa

3.2

15.4

245

F29

ICPC

Eye symptom/complaint other

1.7

15.1

298

1753

WX144

NOMESCO Finland

Subconjunctival anesthesy

2.7

15.0

101

371

AN1

Coronary angiography

1.4

15.0

754

5532

M02AA07

ATC

piroxicam; topical

1.3

14.8

1760

14722

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

14.8

339

2077

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

14.8

430

2805

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.9

14.8

224

1209

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

14.7

318

1920

R09

ICPC

Sinus symptom/complaint

2.0

14.6

179

891

D01BA02

ATC

terbinafine; oral; topical

1.4

14.4

958

7368

RK530

NOMESCO Finland

149.5

14.4

S04

ICPC

Lump/swelling localized

1.7

14.4

336

2072

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

14.3

248

1398

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

14.3

915

6995

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

14.3

774

5753

R06.5

ICD-10 Finland

Mouth breathing

1.8

14.2

238

1328

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

11.3

14.2

C01DA14

ATC

isosorbide mononitrate; oral

1.3

14.2

1318

10656

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.5

14.2

109

437

U01

ICPC

Dysuria/painful urination

1.7

14.1

296

1772

R07

ICPC

Sneezing/nasal congestion

2.2

14.1

140

637

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

14.1

292

1743

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

14.1

811

6090

SPAT1359

SPAT

Use of symptom diary

2.4

14.0

116

483

-30

ICPC

Medical examin/health eval complete

2.2

13.9

141

647

RK290

NOMESCO Finland

10.8

13.9

KED22

NOMESCO Finland

Transurethral resection of prostate

1.6

13.9

406

2657

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

13.8

505

3471

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

13.8

150

709

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

13.8

301

1822

C03CA01

ATC

furosemide; systemic

1.3

13.7

2252

19560

F03

ICPC

Eye discharge

1.9

13.6

192

1008

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.6

13.6

328

2042

XKC03

NOMESCO Finland

Water cystometry

2.1

13.5

146

690

F16

ICPC

Eyelid symptom/complaint

2.0

13.5

177

904

SPAT1351

SPAT

Extensive ear examination

5.3

13.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

13.4

533

3735

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

13.4

1000

7827

T16

ICD-10 Finland

Foreign body in ear

5.3

13.3

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

13.3

1158

9265

N06AX11

ATC

mirtazapine; oral

1.3

13.3

1249

10099

S02.51

ICD-10 Finland

Fracture of tooth, open

1.7

13.3

271

1610

T90

ICPC

Diabetes non-insulin dependent

1.3

13.3

1060

8372

L28

ICPC

Limited function/disability (L)

1.3

13.3

920

7113

K76

ICPC

Ischaemic heart dis without angina

2.1

13.2

155

760

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

2.0

13.1

159

789

D02

ICPC

Abdominal pain epigastric

1.9

13.1

190

1009

WX402

NOMESCO Finland

General anaesthesia

1.5

13.1

476

3273

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

13.1

1725

14569

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

13.0

765

5756

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.7

13.0

270

1613

Z00.8

ICD-10 Finland

Other general examinations

1.7

13.0

261

1542

M02AA10

ATC

ketoprofen; topical

1.4

12.9

684

5056

R55

ICD-10 Finland

Syncope and collapse

1.4

12.9

619

4494

H65.2

ICD-10 Finland

Chronic serous otitis media

4.2

12.9

115

N03AX16

ATC

pregabalin; oral

1.3

12.7

915

7113

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

12.7

402

2676

A11

ICPC

Chest pain NOS

1.6

12.6

339

2172

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

12.6

545

3881

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

12.6

127

584

38699

ICD-8 Finland

4.8

12.5

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

12.5

260

1553

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

12.5

R35

ICD-10 Finland

Polyuria

1.6

12.5

301

1876

R60.0

ICD-10 Finland

Localized oedema

1.4

12.4

561

4026

H40.0

ICD-10 Finland

Glaucoma suspect

1.6

12.4

350

2268

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

12.4

404

2712

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

12.4

673

4996

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

12.3

1318

10833

R96

ICPC

Asthma

1.6

12.2

327

2091

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.9

12.2

254

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

12.2

309

1952

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

12.1

933

7324

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

12.1

149

746

C05AA08

ATC

fluocortolone; rectal, topical

1.4

12.0

551

3965

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

12.0

507

3590

M01AX17

ATC

nimesulide; oral

1.3

12.0

1102

8867

N01

ICPC

Headache

1.7

12.0

238

1403

-54

ICPC

Repair/fix-suture/cast/prosth device

2.2

12.0

120

550

S06.0

ICD-10 Finland

Concussion

1.5

12.0

414

2814

S01EE01

ATC

latanoprost; ophthalmic

1.5

11.9

406

2749

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

11.9

843

6530

RK510

NOMESCO Finland

10.0

11.9

F05

ICPC

Visual disturbance other

2.2

11.9

121

558

R44

ICPC

Respiratory, Preventive immunization/medic

2.4

11.8

404

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

11.8

296

1860

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

11.8

740

5623

XQ848

NOMESCO Finland

Dermatological photography

2.1

11.8

124

582

C10AA07

ATC

rosuvastatin; oral

1.3

11.8

961

7602

WZC30

NOMESCO Finland

Teaching

1.5

11.8

465

3249

K05

ICPC

Irregular heartbeat other

1.9

11.8

163

852

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

4.3

11.8

H03

ICPC

Tinnitus, ringing/buzzing ear

3.0

11.7

215

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

11.7

738

5619

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.7

275

1704

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

11.6

333

2168

D01AE16

ATC

amorolfine; topical

1.4

11.6

502

3571

R04.0

ICD-10 Finland

Epistaxis

1.5

11.6

389

2626

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

11.6

1020

8154

D06

ICPC

Abdominal pain localized other

1.7

11.6

261

1596

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

11.6

266

1637

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.4

11.6

493

3501

J01FA09

ATC

clarithromycin; systemic

1.3

11.6

950

7522

Z51.88

ICD-10 Finland

Other specified medical care

2.2

11.5

111

498

WX780

NOMESCO Finland

Remote monitoring CPAP

2.4

11.5

398

J05AB01

ATC

aciclovir; systemic

1.3

11.5

758

5807

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

11.4

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

11.4

H91.0

ICD-10 Finland

Ototoxic hearing loss

+∞

11.4

SPAT1281

SPAT

Other administrative function

1.6

11.4

323

2096

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

11.4

282

1767

L90

ICPC

Osteoarthrosis of knee

1.6

11.4

279

1747

RK322

NOMESCO Finland

13.5

11.4

D19

ICPC

Teeth/gum symptom/complaint

1.4

11.4

656

4913

D11

ICPC

Diarrhoea

1.6

11.4

305

1953

C09CA06

ATC

candesartan; oral

1.3

11.2

846

6615

N30.0

ICD-10 Finland

Acute cystitis

1.4

11.2

666

5018

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

11.1

435

3035

XF404

NOMESCO Finland

Ambulatory ECG

1.5

11.1

436

3043

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.0

11.1

135

673

A06AC51

ATC

ispaghula, combinations; systemic

1.8

11.1

205

1181

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

11.1

160

851

C08CA13

ATC

lercanidipine; oral

1.4

11.1

686

5202

A02BA02

ATC

ranitidine; systemic

1.3

11.1

1051

8481

R06AX27

ATC

desloratadine; oral

1.4

11.1

614

4572

ZXA05

NOMESCO Finland

Left side

1.3

11.1

1290

10686

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

11.0

566

4155

DC1AD

NOMESCO Finland

Temporalbone CT

6.4

11.0

H02.3

ICD-10 Finland

Blepharochalasis

1.6

11.0

274

1723

K22

ICPC

Risk factor cardiovascular disease

1.6

10.9

253

1558

VALMI

NOMESCO Finland

1.4

10.9

650

4895

H66.9

ICD-10 Finland

Otitis media, unspecified

2.2

10.9

108

495

D01

ICPC

Abdominal pain/cramps general

1.5

10.9

329

2172

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

10.9

295

1895

SCA03

NOMESCO Finland

Preventive oral health care, extensive

2.1

10.8

121

584

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

10.8

1120

9142

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

10.7

489

3515

S01

ICPC

Pain/tenderness of skin

1.8

10.7

169

928

D12

ICPC

Constipation

1.8

10.7

180

1008

D07AC13

ATC

mometasone; topical

1.3

10.7

1082

8802

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

11.1

10.5

L05

ICPC

Flank/axilla symptom/complaint

1.7

10.5

210

1244

R31

ICD-10 Finland

Unspecified haematuria

1.4

10.5

545

4013

H27

ICPC

Fear of ear disease

3.7

10.4

119

K78

ICPC

Atrial fibrillation/flutter

1.4

10.4

504

3667

H25.8

ICD-10 Finland

Other senile cataract

1.3

10.3

718

5540

SPAT1291

SPAT

Other function in accordance with NCSP classification

2.5

10.3

313

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

10.3

235

1443

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

10.3

545

4027

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

10.3

919

7350

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.5

10.3

1579

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

10.3

635

4812

DDA00

NOMESCO Finland

Stapedotomy

8.1

10.2

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

10.2

608

4583

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

10.2

380

2626

R15

ICD-10 Finland

Faecal incontinence

2.0

10.1

129

655

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

10.1

1685

14513

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

10.0

190

1106

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.6

10.0

272

1750

SPAT1059

SPAT

Spirometry at the office

1.7

10.0

204

1217

H71

ICD-10 Finland

Cholesteatoma of middle ear

3.6

10.0

119

H51

ICPC

Ear, I&d/flush/aspiration

2.5

10.0

292

M01AE02

ATC

naproxen; oral, rectal

1.2

9.9

1968

17244

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

9.9

457

3292

N02AX02

ATC

tramadol; systemic, rectal

1.2

9.9

1848

16094

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

9.9

697

5388

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

5.3

9.9

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

9.8

686

5297

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.7

9.8

237

H80

ICD-10 Finland

Otosclerosis

25.9

9.8

R06AE09

ATC

levocetirizine; oral

1.5

9.8

354

2434

ZXA00

NOMESCO Finland

Right side

1.2

9.8

1348

11361

-60

ICPC

Result test/procedure

1.6

9.7

278

1813

L04

ICPC

Chest symptom/complaint

1.7

9.7

201

1205

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

9.6

658

5058

S06

ICPC

Rash localized

1.6

9.6

222

1369

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

9.6

460

3336

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

9.6

840

6692

S02

ICPC

Pruritus

1.9

9.6

130

679

D21

ICPC

Swallowing problem

2.5

9.6

287

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

9.5

1076

8858

H61.8

ICD-10 Finland

Other specified disorders of external ear

3.2

9.5

145

S22

ICPC

Nail symptom/complaint

1.6

9.5

227

1412

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

9.5

194

1159

-45

ICPC

Observ/health educat/advice/diet

1.9

9.5

129

675

SPAT1216

SPAT

Assessment of functional ability

1.3

9.5

835

6658

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

9.5

636

4879

H70.1

ICD-10 Finland

Chronic mastoiditis

7.1

9.4

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

9.4

489

M48.0

ICD-10 Finland

Spinal stenosis

1.3

9.4

624

4777

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.3

9.4

683

RK111

NOMESCO Finland

99.6

9.4

R01AD11

ATC

triamcinolone; nasal

1.6

9.4

259

1673

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

9.4

124

642

T92

ICPC

Gout

2.1

9.4

101

480

J01EA01

ATC

trimethoprim; systemic

1.2

9.4

1261

10592

YHMAS

NOMESCO Finland

4.4

9.4

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

9.4

SPAT1118

SPAT

Haemorrhoid procedure

4.9

9.3

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.5

9.3

344

2373

-50

ICPC

Medication/prescr/renewal

1.7

9.3

200

1213

G04BD09

ATC

trospium; oral

1.9

9.2

139

754

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

9.2

224

1403

114

Kela drug reimbursment

Glaucoma

1.3

9.2

589

4487

WX704

NOMESCO Finland

Intubation

1.6

9.1

228

1438

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

2.1

9.1

448

Z01.2

ICD-10 Finland

Dental examination

1.3

9.1

1082

8956

WX002

NOMESCO Finland

Sedation and analgesia

1.3

9.1

862

6940

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

9.0

779

6194

S97

ICPC

Chronic ulcer skin

1.5

9.0

278

1845

R52.9

ICD-10 Finland

Pain, unspecified

1.5

9.0

294

1974

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

9.0

905

7336

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

9.0

1501

12893

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.5

9.0

285

1904

AN2

Balloon angioplasty, including several vessels

1.7

9.0

166

962

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

8.9

312

2125

SPAT1044

SPAT

Tympanometry

2.7

8.9

215

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

8.9

403

2892

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.7

8.9

174

1026

-35

ICPC

Urine test

2.6

8.8

227

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.6

8.8

242

1565

N39.3

ICD-10 Finland

Stress incontinence

1.6

8.8

251

1637

L18

ICPC

Muscle pain

1.8

8.8

139

768

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

8.8

252

1643

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

8.8

616

4757

S01BC05

ATC

ketorolac; ophthalmic

1.5

8.7

282

1892

R75

ICPC

Sinusitis acute/chronic

2.1

8.7

470

R13

ICD-10 Finland

Dysphagia

1.5

8.7

277

1853

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

8.7

108

548

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

8.7

350

2459

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.7

1356

11561

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.6

352

2477

WX290

NOMESCO Finland

Other blockade of nerve

1.3

8.6

915

7467

SPAT1229

SPAT

Assessment of need for aid

1.4

8.6

423

3082

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

8.6

147

833

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

8.6

363

2573

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

8.6

883

7178

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.6

2675

24340

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

8.5

229

1472

Y85

ICPC

Benign prostatic hypertrophy

2.2

8.5

381

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.0

8.5

153

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

8.4

175

1050

K02

ICPC

Pressure/tightness of heart

2.0

8.4

108

554

H70

ICPC

Otitis externa

2.5

8.4

254

M01AH02

ATC

rofecoxib; oral

1.3

8.4

625

4864

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

8.4

381

2737

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

4.2

8.4

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

8.4

416

3037

R08

ICPC

Nose symptom/complaint other

2.1

8.4

458

F02

ICPC

Red eye

1.8

8.4

141

797

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

8.3

105

535

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

8.3

706

5602

S15

ICPC

Foreign body in skin

1.6

8.3

228

1475

F70

ICPC

Conjunctivitis infectious

2.4

8.3

262

RK321

NOMESCO Finland

10.7

8.2

F06.7

ICD-10 Finland

Mild cognitive disorder

1.7

8.2

151

876

A10BB01

ATC

glibenclamide; oral

0.7

8.2

201

2959

D17

ICPC

Incontinence of bowel

2.8

8.2

173

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

8.2

136

764

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

8.2

438

3238

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

8.2

134

751

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

2.0

8.2

104

533

H82

ICPC

Vertiginous syndrome

2.2

8.2

366

J02AC01

ATC

fluconazole; systemic

1.2

8.1

1125

9457

H40.11

ICD-10 Finland

Low pressure glaucoma

1.9

8.1

116

619

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

8.1

148

857

A29

ICPC

General symptom/complaint other

1.3

8.1

501

3794

K96

ICPC

Haemorrhoids

2.2

8.1

370

R03BA08

ATC

ciclesonide; inhalant

1.6

8.0

224

1451

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

8.0

467

3503

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

8.0

468

3510

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

7.9

795

6437

H01.0

ICD-10 Finland

Blepharitis

1.7

7.9

144

832

S16

ICPC

Bruise/contusion

1.7

7.9

144

833

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

7.9

809

6567

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.0

7.9

463

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

7.9

191

1200

ZY010

NOMESCO Finland

Hospital outpatient

1.9

7.8

101

520

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.2

7.8

349

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.8

1362

11718

H71

ICPC

Acute otitis media/myringitis

4.2

7.8

F01

ICPC

Eye pain

2.1

7.8

373

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.7

7.8

167

1012

K07

ICPC

Swollen ankles/oedema

1.5

7.8

241

1604

H60

ICD-10 Finland

Otitis externa

1.9

7.8

105

551

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

7.7

242

1612

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.7

1028

8599

C10AA03

ATC

pravastatin; oral

1.4

7.7

386

2824

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.7

538

4151

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.5

7.7

1222

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.1

7.7

380

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.4

7.6

307

2155

L29

ICPC

Musculoskeletal sympt/complt other

1.5

7.6

286

1982

S70.0

ICD-10 Finland

Contusion of hip

1.6

7.6

198

1263

H05

ICPC

Bleeding ear

4.2

7.6

F21

ICPC

2.2

7.6

327

XKX00

NOMESCO Finland

Pelvic floor electromyography

5.5

7.6

A06AD11

ATC

lactulose; oral

1.2

7.6

960

7983

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.6

516

3962

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.5

7.6

271

1860

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.2

7.6

115

D40

ICPC

Digestive, Diagnostic endoscopy

4.3

7.6

XF402

NOMESCO Finland

ECG with work load test

1.3

7.5

477

3625

G04BD11

ATC

fesoterodine; oral

1.7

7.5

156

938

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

7.5

242

1624

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

4.5

7.5

RK220

NOMESCO Finland

5.1

7.5

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

3.0

7.5

133

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

7.5

570

4451

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.6

7.4

185

1169

R81

ICPC

Pneumonia

1.8

7.4

131

752

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

7.4

175

1093

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.6

7.4

206

1336

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

7.3

278

1933

S01.0

ICD-10 Finland

Open wound of scalp

1.4

7.3

333

2397

SPAT1251

SPAT

Organisation of medication

1.6

7.3

205

1332

SPAT1098

SPAT

Exercise ECG

2.0

7.3

441

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

7.3

105

564

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

7.3

167

1034

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

7.3

H81.2

ICD-10 Finland

Vestibular neuronitis

2.2

7.2

294

N04BC05

ATC

pramipexole; oral

1.4

7.2

310

2207

R05FB02

ATC

cough suppressants and expectorants

1.2

7.2

1712

15134

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

7.2

286

2007

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

7.2

158

969

S08

ICPC

Skin colour change

1.6

7.2

199

1292

R03DC03

ATC

montelukast; oral

1.3

7.2

430

3244

H31

ICPC

Ear, Medical examin/health eval partial

7.2

7.1

G04BD07

ATC

tolterodine; oral

1.4

7.1

303

2150

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

7.1

186

1189

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

7.1

203

1326

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

7.1

626

4983

H03AA01

ATC

levothyroxine sodium; systemic

1.2

7.1

909

7566

U05

ICPC

Urination problems other

1.5

7.1

224

1497

EMAK

NOMESCO Finland

1.9

7.1

103

556

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.1

1608

14158

R03BA05

ATC

fluticasone; inhalant

1.3

7.1

619

4925

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

7.0

292

2063

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

7.0

514

D16

ICPC

Rectal bleeding

2.0

7.0

408

A10

ICPC

Bleeding/haemorrhage NOS

2.8

7.0

151

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

7.0

250

1717

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

6.9

192

J01CA08

ATC

pivmecillinam; oral

1.2

6.9

1603

14126

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

6.9

278

1954

SPAT1234

SPAT

Support of social functional capacity

1.4

6.9

274

1923

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

6.9

261

1812

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

6.9

639

5120

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

3.6

6.9

A08

ICPC

Swelling

1.5

6.8

196

1287

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

9.3

6.7

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

6.7

106

587

SPAT1101

SPAT

Orthostatic test

1.4

6.7

256

1782

DFX03

SPAT

39.8

6.7

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.7

6.7

149

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

6.7

500

H25.0

ICD-10 Finland

Senile incipient cataract

1.4

6.7

316

2288

TKD00

NOMESCO Finland

Dilatation of urethra

2.6

6.7

183

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.3

6.7

418

B02.9

ICD-10 Finland

Zoster without complication

1.5

6.7

239

1643

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

6.6

292

2088

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

6.6

716

5847

L86

ICPC

Back syndrome with radiating pain

1.5

6.6

185

1203

B01AF01

ATC

rivaroxaban; oral

1.3

6.6

531

4178

SPAT1039

SPAT

Otomicroscopy

2.4

6.6

212

S70

ICPC

Herpes zoster

1.8

6.6

101

556

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

2.9

6.6

123

B01AA03

ATC

warfarin; systemic

1.2

6.6

1435

12578

S09

ICPC

Infected finger/toe

1.8

6.6

108

607

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

6.5

133

798

G03CA04

ATC

estriol; systemic, vaginal

1.3

6.5

479

3725

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

1.6

6.5

167

1066

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

6.5

336

2472

J01FA06

ATC

roxithromycin; oral

1.2

6.5

1588

14049

N06AX21

ATC

duloxetine; oral

1.4

6.5

283

2023

UDM02

NOMESCO Finland

Sinoscopy

2.2

6.5

278

B81

ICPC

Anaemia vit B12/folate deficiency

1.5

6.5

197

1309

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

6.4

160

1013

A02BC04

ATC

rabeprazole; oral

1.5

6.4

222

1515

N05CF01

ATC

zopiclone; oral

1.2

6.4

1633

14488

M10.9

ICD-10 Finland

Gout, unspecified

1.4

6.4

311

2263

F92

ICPC

Cataract

2.6

6.4

159

W19

ICD-10 Finland

Unspecified fall

1.3

6.4

401

3048

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

6.4

599

4811

R03BA01

ATC

beclometasone; inhalant

1.3

6.4

554

4402

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

6.4

276

1969

S10

ICPC

Boil/carbuncle

1.6

6.4

167

1072

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.4

601

4827

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

6.3

114

662

A01

ICPC

Pain general/multiple sites

1.4

6.3

307

2235

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

6.3

194

1290

F13

ICPC

Eye sensation abnormal

1.9

6.3

448

N35.9

ICD-10 Finland

Urethral stricture, unspecified

2.2

6.3

263

H92.2

ICD-10 Finland

Otorrhagia

8.1

6.3

-40

ICPC

Diagnostic endoscopy

4.4

6.3

L92

ICPC

Shoulder syndrome

2.0

6.3

397

SPAT1016

SPAT

Examination of vision

1.5

6.3

171

1110

N05AD01

ATC

haloperidol; systemic

0.6

6.3

1215

ACC51

NOMESCO Finland

Release of median nerve

1.5

6.3

201

1354

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.3

6.3

373

2809

A51

ICPC

General and Unspecified, I&d/flush/aspiration

5.5

6.3

WNF00

NOMESCO Finland

Infection source and contact determination

3.4

6.3

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

6.2

311

K04.0

ICD-10 Finland

Pulpitis

1.6

6.2

135

824

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

6.2

102

575

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

6.2

SPAT1054

SPAT

Examination of peripheral nervous system

2.0

6.2

337

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.2

357

2676

XX2VW

NOMESCO Finland

Radiologic consultation

3.7

6.2

R07.0

ICD-10 Finland

Pain in throat

1.7

6.2

131

794

S01ED51

ATC

timolol, combinations; ophthalmic

1.3

6.2

438

3385

H74.1

ICD-10 Finland

Adhesive middle ear disease

7.0

6.2

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.6

6.2

154

978

R29

ICPC

Respiratory symptom/complaint other

1.5

6.2

180

1184

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.3

6.2

230

R33

ICD-10 Finland

Retention of urine

1.3

6.2

454

3532

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.6

6.1

160

1027

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

6.1

497

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

6.1

501

3957

C09CA03

ATC

valsartan; oral

1.3

6.1

383

2911

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.1

6.1

299

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

6.1

137

849

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

6.1

194

1304

A01AB09

ATC

miconazole; local oral

1.3

6.1

402

3081

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

6.1

353

2653

K01

ICPC

Heart pain

2.0

6.0

349

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.0

189

1265

L11

ICPC

Wrist symptom/complaint

1.5

6.0

211

1448

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

6.0

460

3596

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002385) Erythrocyte distribution width [Ratio]

4258

30575

2.34

187.40

24.5

23.6

14.0

14.1

5.39

4112

29667

(40761536) Microorganisms panel - Urine sediment

929

3589

2.86

167.06

5.4

4.6

—

(40761511) CBC panel - Blood by Automated count

4925

39028

2.45

151.51

21.7

18.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1860

10288

2.16

150.25

4.6

4.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5032

40371

2.51

148.62

24.3

22.7

umol/l

89.0

86.8

3.42

5032

40345

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4918

39148

2.41

146.23

20.4

19.2

mg/l

26.1

29.0

8.27

4222

32870

(3019550) Sodium [Moles/volume] in Serum or Plasma

5093

41201

2.55

145.61

25.3

23.2

mmol/l

139.3

139.4

1.39

4945

39819

(3023103) Potassium [Moles/volume] in Serum or Plasma

5096

41248

2.55

145.31

25.7

23.4

mmol/l

4.0

0.26

4939

39789

(3031040) Bacteria [#/volume] in Urine by Automated count

4067

30242

2.06

140.93

6.1

5.6

e6/l

1806.0

2376.0

0.35

124

569

(3035941) MCH [Entitic mass]

5109

41586

2.53

140.54

30.1

27.7

30.4

0.60

4993

40446

(3010813) Leukocytes [#/volume] in Blood

5110

41598

2.53

140.53

30.3

27.9

e9/l

7.2

7.1

0.35

4913

39671

(3024731) MCV [Entitic volume]

5109

41588

2.53

140.49

30.2

27.8

92.1

92.0

0.59

4993

40446

(3026361) Erythrocytes [#/volume] in Blood

5109

41588

2.53

140.49

30.2

27.9

e12/l

4.3

2.06

4903

39657

(3007461) Platelets [#/volume] in Blood

5108

41584

2.52

140.28

30.2

27.9

e9/l

230.9

237.9

11.43

4937

39886

(3000963) Hemoglobin [Mass/volume] in Blood

5109

41596

2.52

140.28

30.5

28.1

g/l

129.1

129.4

0.79

4990

40471

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4972

40184

2.37

135.50

11.7

11.1

u/l

23.0

23.5

0.70

4605

38012

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4576

35782

2.16

135.18

6.8

mmol/mol

41.9

41.6

1.41

3832

31940

(3037467) Urinalysis macro (dipstick) panel - Urine

3984

29773

1.99

131.17

5.4

5.0

—

(3032080) INR in Blood by Coagulation assay

3066

21006

1.93

130.66

15.4

11.7

inr

1.3

1.4

2.51

1275

5538

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

969

4311

2.48

128.92

4.2

3.8

mmol/l

1.2

0.44

764

3705

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4492

35142

2.09

128.53

5.2

4.8

mu/l

2.1

0.27

3741

30902

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1125

5379

2.33

127.16

4.3

4.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4646

37017

2.11

123.38

5.4

5.1

mmol/l

6.1

6.2

0.78

3618

32222

(3021589) Normoblasts [#/volume] in Blood

2670

17713

1.90

123.10

13.5

10.4

e9/l

0.0

0.22

2199

14190

(3018418) pH of Serum or Plasma

2357

15055

1.92

121.64

4.3

3.8

7.4

2.16

675

2764

(3044889) 12 lead EKG panel

3825

28610

1.92

120.26

5.2

4.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4619

36909

2.08

118.87

5.5

5.3

mmol/l

2.4

2.5

9.45

3679

32547

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4485

35470

2.03

118.67

4.8

4.6

mmol/l

4.2

4.3

7.40

3660

31374

(3013707) Erythrocyte sedimentation rate by Westergren method

3913

29579

1.91

117.97

4.6

4.2

mm/h

16.2

16.5

0.53

3358

26628

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4222

32733

1.96

117.86

7.4

7.3

u/l

82.6

83.4

0.32

3818

30343

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4417

35014

1.98

112.28

4.8

4.6

mmol/l

1.4

3.47

3483

30711

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3123

22233

1.83

111.02

5.6

5.7

mmol/l

1.2

3.87

2703

19835

(1761868) Lipid panel - Serum or Plasma

1524

8618

2.02

110.31

3.8

3.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3776

28630

1.85

107.81

4.2

3.9

pmol/l

15.2

0.16

3090

25044

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3363

24670

1.81

106.45

6.2

6.3

mmol/l

1.2

3.40

2470

20453

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4273

33812

1.90

104.97

4.1

mmol/l

1.2

3.03

3323

29249

(3013826) Glucose [Moles/volume] in Serum or Plasma

3561

26721

1.81

102.95

4.7

mmol/l

6.9

7.0

0.79

3384

25011

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1777

10831

1.90

101.81

1.9

1.7

pmol/l

7315517.7

16042031.9

0.53

1203

8559

(3009261) Glucose [Presence] in Urine by Test strip

2916

20731

1.78

100.34

4.6

4.4

estimate

0.0

0.50

908

3748

(3035350) Ketones [Presence] in Urine by Test strip

2888

20485

1.78

100.07

4.5

4.3

estimate

0.0

0.00

927

3825

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4415

35564

1.90

99.28

21.3

18.9

ml/min/173m2

65.9

67.5

5.70

3767

29430

(3009542) Hematocrit [Volume Fraction] of Blood

4137

32728

1.84

97.58

22.8

21.6

37.2

0.15

2105

19057

(3021601) Nitrite [Presence] in Urine by Test strip

2870

20470

1.76

96.23

5.7

5.9

estimate

0.0

0.00

911

3764

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1550

9206

1.91

95.02

1.6

mmol/l

1.3

0.54

958

7584

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2292

15374

1.78

94.65

4.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1806

11278

1.85

94.55

4.9

4.8

estimate

0.0

0.34

864

3560

(3000850) Epithelial cells [#/volume] in Urine

1772

11091

1.84

91.53

3.0

2.8

e6/l

5.5

5.3

0.31

1539

9719

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2502

17352

1.75

90.97

2.3

2.2

nmol/l

82.0

80.4

1.86

2043

14786

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2696

19167

1.73

89.10

5.0

4.4

ng/l

89.0

90.6

0.02

2179

15304

(3002582) Erythrocytes [#/volume] in Urine

2254

15608

1.70

79.33

3.8

3.6

e6/l

222.8

95.1

0.93

1788

12147

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1979

13472

1.69

72.68

2.5

u/l

61.2

59.4

0.34

1752

12274

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2284

16142

1.66

72.63

2.3

2.2

—

(3018095) Leukocytes [#/volume] in Urine

2420

17365

1.65

72.44

4.4

4.1

e6/l

147.9

149.3

0.02

1854

12772

(40767503) Oxygen content in Capillary blood by calculation

336

1158

3.00

72.36

2.7

2.5

16.0

15.7

0.64

170

602

(40760892) CBC W Ordered Manual Differential panel - Blood

1243

7450

1.83

71.17

4.8

4.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2438

17651

1.63

69.59

3.4

3.2

ng/l

2287.8

2291.8

0.01

1999

15400

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2195

15516

1.64

68.73

6.0

5.6

ug/l

7.6

5.0

0.44

1749

13482

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2331

16791

1.62

67.26

3.1

2.9

ug/l

168.5

155.3

0.42

1921

14967

(3006504) Eosinophils/100 leukocytes in Blood

2565

18956

1.61

66.29

5.5

2.7

2.8

0.55

2314

17260

(36304419) Bacteria [Presence] in Urine

1975

13693

1.65

66.17

3.7

3.5

—

(3019069) Monocytes/100 leukocytes in Blood

2572

19034

1.60

65.99

5.8

9.1

9.0

0.58

2323

17381

(3022096) Basophils/100 leukocytes in Blood

2510

18502

1.60

65.24

5.5

0.6

0.05

2265

16874

(3025159) Blasts/100 leukocytes in Blood

637

3119

2.15

64.97

3.9

3.6

0.5

0.3

0.30

161

826

(3002030) Lymphocytes/100 leukocytes in Blood

2591

19329

1.59

63.46

5.6

5.7

24.7

24.6

0.15

2320

17539

(3030467) Casts [#/volume] in Urine by Automated count

2025

14283

1.62

62.48

3.7

3.5

e6/l

0.6

0.10

1591

10983

(3012501) Base excess in Blood by calculation

327

1206

2.80

62.10

3.9

4.5

mmol/l

2.6

2.9

1.10

200

844

(42870588) Differential panel, method unspecified - Blood

2028

14331

1.62

61.97

5.0

5.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2997

23203

1.57

61.96

5.4

5.7

umol/l

12.8

12.7

0.11

2796

21815

(3013290) Carbon dioxide [Partial pressure] in Blood

327

1208

2.79

61.90

3.9

4.5

kpa

4.9

5.0

3.45

321

1167

(3027315) Oxygen [Partial pressure] in Blood

327

1210

2.79

61.71

3.9

4.5

kpa

8.4

8.2

1.21

321

1168

(3018010) Neutrophils/100 leukocytes in Blood

2540

18963

1.58

61.33

5.3

5.5

60.0

59.9

0.17

2276

17303

(3028271) Lactate [Moles/volume] in Capillary blood

263

872

3.09

60.50

2.0

1.9

mmol/l

1.6

1.7

0.22

258

852

(3026008) Bacteria identified in Urine by Culture

2367

17496

1.57

58.99

3.9

3.7

—

(3026782) Osmolality of Urine

1568

10550

1.65

57.54

3.1

2.9

mosm/kgh2o

512.2

544.9

9.52

1333

8912

(3002179) Metamyelocytes/100 leukocytes in Blood

622

3170

2.06

56.75

3.8

3.5

0.5

0.6

0.39

147

755

(3017181) Myelocytes/100 leukocytes in Blood

671

3556

1.99

54.83

3.9

3.6

0.9

0.07

177

1093

(3021440) Promyelocytes/100 leukocytes in Blood

646

3379

2.01

54.78

4.0

3.6

0.1

0.04

171

1019

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1766

12413

1.59

53.42

5.3

4.8

22.5

0.04

884

6790

(3021960) Folate [Moles/volume] in Serum or Plasma

1816

12859

1.58

53.17

1.7

1.6

nmol/l

20.2

19.7

0.57

1423

10935

(3013115) Eosinophils [#/volume] in Blood

2664

20559

1.52

52.66

5.2

5.3

e9/l

0.2

0.02

2289

17325

(3010421) pH of Blood

339

1386

2.52

52.29

3.9

4.3

7.4

1.23

322

1167

(3019309) Folate [Moles/volume] in Red Blood Cells

1716

12040

1.59

52.04

2.0

1.8

nmol/l

1212.9

1163.7

1.18

1163

8773

(3001604) Monocytes [#/volume] in Blood

2578

19873

1.51

50.52

5.1

e9/l

0.7

0.6

2.21

2139

16502

(3006315) Basophils [#/volume] in Blood

2590

20001

1.51

50.23

5.1

5.2

e9/l

0.0

0.49

2153

16652

(3023368) Bacteria identified in Blood by Culture

2076

15387

1.52

48.45

4.5

4.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2677

20935

1.49

48.11

3.1

u/l

59.0

57.9

0.15

2298

18534

(3019198) Lymphocytes [#/volume] in Blood

2615

20355

1.49

48.08

5.2

5.3

e9/l

1.9

0.04

2253

17171

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1983

14601

1.53

47.50

2.2

2.1

u/l

214.9

223.6

0.20

1808

13493

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1886

13747

1.53

47.31

2.4

2.3

mg/l

3.0

3.2

3.58

1502

11530

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1352

9138

1.61

47.23

1.9

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2722

21443

1.48

46.67

4.5

4.4

g/l

33.9

0.11

2388

19438

(1616796) Gas panel - Central venous blood

300

1225

2.51

46.35

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2922

23490

1.46

44.29

7.5

8.0

e9/l

4.6

4.5

0.48

2506

19960

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1290

8815

1.58

42.38

3.6

3.3

ug/l

0.9

0.11

860

6523

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1151

7721

1.60

40.71

2.6

2.5

g/l

2.2

0.16

1007

7008

(3022948) Iron [Moles/volume] in Serum or Plasma

1220

8308

1.58

40.43

2.6

2.5

umol/l

11.5

11.3

0.55

1097

7516

(3006184) Hemoglobin [Mass/volume] in Capillary blood

290

1243

2.39

40.28

2.6

2.2

g/l

127.1

125.4

0.59

254

924

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1100

7329

1.60

39.94

2.7

2.6

21.2

20.4

1.28

868

6154

(3015377) Calcium [Moles/volume] in Serum or Plasma

2154

16635

1.45

38.58

3.0

3.2

mmol/l

2.3

2.4

1.43

1786

13974

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2638

21174

1.43

38.17

2.2

pmol/l

92.0

91.2

0.37

1253

10781

(3000012) Reticulocyte production index

114

334

3.44

32.16

1.6

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

962

6515

1.56

31.84

1.9

1.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

198

797

2.52

31.53

3.6

3.4

56.6

60.0

2.67

198

797

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

955

6495

1.55

30.93

1.9

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1541

11562

1.44

30.66

3.1

3.0

u/l

38.7

37.7

0.14

1396

10756

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1422

10522

1.45

30.45

4.8

4.3

ng/l

263.4

465.1

1.34

1307

9401

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

511

2976

1.77

30.39

5.2

5.8

mmol/l

24.5

25.0

2.04

505

2935

(3026493) Urate [Moles/volume] in Serum or Plasma

1486

11166

1.43

29.06

2.8

2.9

umol/l

4840.7

8063.2

1.82

1131

9225

(3047181) Lactate [Moles/volume] in Blood

293

1443

2.07

28.93

4.7

5.2

mmol/l

1.4

0.03

243

1277

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1207

8751

1.47

28.48

1.6

mg/l

1.5

1.6

0.34

902

6861

(40768797) Stomach Pathology biopsy report

802

5347

1.57

28.17

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

829

5617

1.54

27.02

3.7

3.1

ng/l

260.7

296.2

1.56

758

5140

(40768804) Tissue Pathology biopsy report

1968

15689

1.37

26.68

2.4

2.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

929

6486

1.50

26.25

1.3

1.2

u/ml

1.6

0.04

204

1496

(3012516) Albumin [Mass/volume] in Urine

1731

13613

1.37

25.24

3.3

3.1

mg/l

582.9

357.6

0.89

1022

8731

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

212

971

2.22

25.23

3.4

2.4

mg/l

1.9

0.10

180

842

(3013512) EKG study

1713

13477

1.37

24.83

4.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2359

19508

1.34

24.57

4.6

4.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

165

687

2.43

24.50

4.1

9.7

mmol/l

7.2

7.5

0.50

135

565

(3022145) Colonoscopy Study observation

610

3959

1.59

23.85

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1067

7798

1.44

23.62

1.8

1.9

30.4

30.3

0.46

1017

7519

(3015235) Bicarbonate [Moles/volume] in Capillary blood

282

1477

1.94

23.43

2.8

3.2

mmol/l

25.0

25.1

0.11

262

1285

(3021901) Oxygen saturation in Capillary blood

233

1148

2.06

23.00

2.7

2.8

—

(3009508) Creatinine [Moles/volume] in Urine

1712

13623

1.35

22.63

3.3

3.1

mmol/l

6.4

6.7

1.64

1223

11009

(3007164) IgA [Mass/volume] in Serum or Plasma

820

5742

1.49

22.58

1.7

1.4

g/l

2.7

2.8

0.59

431

3031

(3042631) Mycobacterium sp identified in Specimen

170

747

2.30

22.37

3.5

2.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

118

438

2.71

22.22

1.6

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

953

6896

1.45

22.12

2.5

2.2

1.8

0.22

797

5910

(3028626) Oxygen [Partial pressure] in Capillary blood

254

1321

1.95

21.55

2.6

2.9

kpa

7.8

7.7

0.49

241

1228

(3023520) Reticulocytes [#/volume] in Blood

722

5048

1.48

19.88

3.0

2.4

e9/l

66.9

67.9

0.31

532

3756

(3018572) Chloride [Moles/volume] in Blood

204

1012

2.04

19.80

5.2

5.8

mmol/l

104.6

105.0

0.47

179

900

(3039000) Anion gap in Blood

204

1012

2.04

19.80

5.2

5.8

mmol/l

11.4

11.2

0.38

179

900

(3036481) Cortisol [Moles/volume] in Serum or Plasma

510

3316

1.58

19.67

1.9

2.1

nmol/l

380.3

388.4

0.35

463

2952

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

130

544

2.41

19.17

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

732

5172

1.46

19.07

1.3

iu/ml

50.9

43.0

0.44

240

1580

(3020682) Albumin/Creatinine [Ratio] in Urine

1765

14447

1.31

18.33

4.4

3.8

mg/mmol

10.9

10.4

0.16

960

9083

(3002256) Pathology report gross observation

770

5549

1.44

18.01

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

163

781

2.11

17.41

3.6

3.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

287

2.87

17.33

4.8

3.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

194

996

1.97

17.15

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

252

1413

1.81

16.98

1.2

u/ml

157.3

266.8

3.41

221

1273

(3005719) IgG [Mass/volume] in Serum or Plasma

396

2571

1.57

15.33

3.5

2.6

g/l

10.4

11.0

1.31

349

2300

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

138

652

2.13

15.33

1.6

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

327

2029

1.64

15.29

2.3

1.8

g/l

1.7

1.4

0.62

279

1771

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

362

2306

1.60

15.20

1.9

1.8

ug/l

3.6

2.7

0.34

311

1950

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

196

1053

1.88

15.17

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

293

2.70

15.03

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

294

2.70

14.94

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

362

2334

1.58

14.45

2.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1007

7848

1.33

14.36

2.6

2.7

mmol/l

0.8

0.84

899

7097

(3009343) pH of Capillary blood

461

3159

1.49

13.90

3.3

3.7

7.4

0.75

141

420

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

447

3058

1.49

13.58

3.3

3.6

mmol/l

2.4

2.2

0.61

306

2240

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

660

4855

1.40

13.56

1.2

u/ml

11.8

16.6

0.89

200

1589

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

400

2675

1.52

13.55

7.4

7.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

240

1418

1.71

13.54

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

464

3201

1.48

13.52

3.3

3.7

kpa

5.1

5.2

0.86

426

2914

(40760888) Immunoglobulin light chains.free panel - Serum

244

1452

1.70

13.42

2.9

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

152

790

1.94

13.05

1.6

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

131

647

2.04

13.00

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

551

3972

1.42

12.70

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

418

2866

1.48

12.56

1.5

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

298

1919

1.57

11.99

2.9

ratio

1.4

3.3

1.22

144

(3008152) Bicarbonate [Moles/volume] in Arterial blood

474

3363

1.44

11.92

5.1

5.9

mmol/l

24.5

0.07

432

3134

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

304

1972

1.56

11.85

3.0

2.9

mg/l

46.5

61.5

0.59

198

1609

(3023419) Bacteria identified in Sputum by Culture

120

595

2.03

11.82

2.3

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

320

2.41

11.69

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

304

1979

1.56

11.67

3.0

2.9

mg/l

58.7

87.1

0.48

199

1614

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

270

1717

1.59

11.47

2.8

2.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

192

1119

1.73

11.44

1.2

u/ml

2.3

1.0

0.44

104

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

7.60

11.34

1.1

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

549

4041

1.39

11.19

1.3

titre

448.3

491.7

0.30

145

926

(3004451) EKG impression Narrative

285

2.46

11.13

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

461

3307

1.42

10.91

2.0

1.8

ug/g

172.6

182.5

0.20

322

2495

(3042111) Morphology [Interpretation] in Bone marrow Narrative

159

893

1.79

10.78

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

126

659

1.92

10.70

1.6

1.3

—

(3000494) Fungus identified in Specimen by Culture

557

4141

1.37

10.67

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

348

2.28

10.55

1.6

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1118

9181

1.26

10.35

4.6

5.0

kg/l

1.0

0.10

233

1605

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

728

1.85

10.15

1.6

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

401

2844

1.43

10.12

1.2

—

(3019060) Gas panel - Arterial blood

491

3610

1.38

10.07

3.7

4.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

383

2700

1.44

9.99

2.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

316

2147

1.49

9.97

4.4

4.3

0.9

1.99

286

2025

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

569

4294

1.35

9.90

1.9

g/l

0.2

1.08

494

3891

(3025941) Bacteria identified in Stool by Culture

299

2039

1.48

9.28

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

315

2173

1.47

9.22

4.4

4.3

1.7

1.5

1.61

288

2046

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

609

1.88

9.14

1.5

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

620

4797

1.32

9.09

2.6

2.4

g/l

65.4

65.7

0.51

528

4198

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

540

4097

1.34

9.06

1.5

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1247

10511

1.23

8.97

3.1

3.2

mmol/l

2.5

0.36

1039

8942

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

271

2.33

8.95

2.1

u/field

2.0

2.7

0.35

184

(3003458) Phosphate [Moles/volume] in Serum or Plasma

828

6683

1.27

8.77

5.3

4.9

mmol/l

1.0

0.47

743

6009

(3016502) Oxygen saturation in Arterial blood

699

5535

1.29

8.62

5.4

6.0

95.2

95.0

0.34

657

5300

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

108

585

1.85

8.33

1.6

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

434

3232

1.36

8.23

4.1

2.9

ml/min/173m2

49.9

56.6

4.82

212

1476

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

514

1.89

8.03

1.2

1.4

56.5

65.1

1.02

329

(3016750) Collection duration of Urine

291

2.20

8.03

2.4

2.0

min

479.9

504.6

0.82

203

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.25

7.84

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

622

4914

1.29

7.79

2.4

2.5

umol/l

9.3

10.4

0.54

505

4200

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

437

3312

1.34

7.40

1.5

—

(3003396) Base excess in Arterial blood by calculation

771

6296

1.25

7.34

5.4

5.7

mmol/l

1.3

1.1

0.43

580

4813

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

528

4116

1.30

7.32

3.4

ng/l

106.9

97.4

1.11

381

3397

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

440

5663

0.75

7.31

8.4

9.1

—

(3037756) Immunofixation for Serum or Plasma

196

1299

1.52

7.07

1.5

—

(36660697) Celiac disease serology panel - Serum

311

2251

1.40

7.06

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

277

2.13

6.89

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

764

6277

1.24

6.87

3.7

3.5

u/l

239.6

251.4

2.33

717

5804

(3009214) Lutropin [Units/volume] in Serum or Plasma

321

2.03

6.66

1.2

1.3

u/l

11.8

12.3

0.10

253

(3012565) Volume of 24 hour Urine

192

2.34

6.61

1.8

2.5

1745.3

1751.3

0.01

154

(3042936) Bacteria identified in Isolate by Culture

789

6556

1.23

6.37

1.8

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

310

2285

1.37

6.33

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

295

2.03

6.25

1.9

mu/l

317.3

331.2

0.17

273

(3027801) Oxygen [Partial pressure] in Arterial blood

759

6298

1.23

6.21

5.5

5.7

kpa

11.3

11.6

1.07

703

5896

(3007853) Bacteria identified in Skin by Aerobe culture

641

5225

1.25

6.18

1.9

1.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

759

6301

1.23

6.18

5.5

5.7

kpa

5.0

5.1

1.30

702

5905

(3002173) Hemoglobin [Mass/volume] in Arterial blood

609

4942

1.25

6.11

6.0

6.4

g/l

117.6

118.4

0.42

573

4769

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

465

3653

1.29

6.10

1.8

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

346

1.94

6.09

1.7

mg/l

5.3

4.9

0.27

320

(3003694) ABO and Rh group [Type] in Blood

1069

9219

1.19

5.81

1.4

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.99

5.73

1.5

1.1

mmol/l

0.3

2.6

1.59

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

141

915

1.55

5.68

1.5

1.4

g/l

0.2

0.42

133

858

(3026389) Candida sp identified in Specimen by Organism specific culture

515

1.73

5.65

1.2

1.5

—

(3019977) pH of Arterial blood

349

1.89

5.62

2.1

2.2

7.4

0.23

123

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

372

1.86

5.54

1.2

1.1

u/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.17

5.53

1.6

1.1

u/l

95.8

588.6

0.49

(3003338) MCHC [Mass/volume]

3233

30286

1.13

5.46

28.1

26.0

g/l

330.3

329.9

2.01

3206

29732

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

139

913

1.53

5.32

1.9

1.6

—

(4035726)

482

3872

1.26

5.30

1.4

1.3

—

(3017704) Immunofixation for Urine

293

1.94

5.30

1.5

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.98

5.22

1.1

1.3

ng/l

2790.7

3569.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

163

1112

1.47

5.21

3.6

3.9

mg/l

31.5

0.00

120

766

(3044242) Glucose [Moles/volume] in Arterial blood

325

1.88

5.11

1.8

1.6

—

(3045716) Anion gap in Serum or Plasma

256

1.99

5.09

3.1

1.7

mmol/l

8.5

9.2

0.77

212

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

141

939

1.51

5.08

1.5

1.4

g/l

1.1

1.2

0.95

134

878

(40768443) Skin Pathology biopsy report

254

1883

1.36

5.07

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

2.52

5.05

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

887

0.51

5.03

2.2

2.6

mmol/l

4.0

4.1

0.92

881

(3017446) Testosterone [Moles/volume] in Serum or Plasma

267

2001

1.34

4.97

1.9

2.0

nmol/l

10.8

10.4

0.29

200

1674

(3033705) Calcium.ionized [Moles/volume] in Venous blood

876

0.52

4.85

2.2

2.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

251

1877

1.34

4.76

3.6

3.0

pmol/l

4.4

4.3

0.98

211

1594

(4062490)

271

1.92

4.69

1.5

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

143

973

1.47

4.67

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

619

1.58

4.52

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

458

1.68

4.51

1.8

1.5

g/l

0.5

0.9

2.68

341

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.60

4.50

1.3

mg/l

1.0

0.9

0.10

(3024139) IgG subclass 3 [Mass/volume] in Serum

270

1.89

4.41

1.5

1.2

g/l

0.3

0.5

3.74

191

(3027135) IgG subclass 1 [Mass/volume] in Serum

270

1.89

4.41

1.5

1.2

g/l

5.5

7.3

2.33

189

(3028192) IgG subclass 2 [Mass/volume] in Serum

270

1.89

4.41

1.5

1.2

g/l

2.3

3.0

2.27

189

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

247

1867

1.33

4.38

2.3

2.4

au/ml

37.8

29.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.49

4.29

2.4

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

164

2.13

4.24

1.4

iu/l

37.6

33.1

0.32

136

(1761482) Bacteria [#/volume] in Urine by Culture

114

1662

0.68

4.17

4.1

4.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

106

697

1.52

4.13

1.6

iu/l

4.0

4.1

0.05

195

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

174

2.06

4.04

4.1

4.5

71.9

73.1

0.09

142

(3011544) Albumin [Mass/volume] in Pleural fluid

2.92

3.96

1.1

1.2

g/l

17.7

16.6

0.27

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

203

1.97

3.95

1.1

u/l

78.4

91.6

0.67

140

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

203

1.97

3.95

1.1

u/l

22.0

37.7

1.31

135

(3027456) Digoxin [Moles/volume] in Serum or Plasma

234

1795

1.31

3.79

3.5

3.3

nmol/l

0.8

1.25

191

1394

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.78

3.77

1.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

297

2352

1.27

3.76

3.4

e9/l

4.5

4.4

0.13

189

1600

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

2.31

3.70

1.5

1.1

mmol/l

1.7

1.5

0.38

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

392

1.66

3.68

1.2

1.4

38.3

26.4

1.13

250

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

945

8354

1.15

3.66

3.5

3.2

e6/l

3.3

2.6

0.70

507

4656

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

198

1492

1.33

3.65

1.1

iu/ml

98.9

136.1

0.69

469

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

106

718

1.48

3.63

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

126

884

1.43

3.60

1.7

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

567

4832

1.18

3.53

6.1

5.7

mmol/l

12.5

12.1

0.52

520

4495

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

111

2.25

3.50

1.1

ratio

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

137

2.11

3.49

1.2

1.4

—

(3008295) Osmolality of Serum or Plasma

460

1.59

3.49

1.5

1.3

mosm/kgh2o

273.3

274.8

0.21

312

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

476

1.57

3.48

1.9

u/ml

166.8

2572.8

—

(3022621) pH of Urine by Test strip

383

3152

1.22

3.46

3.7

3.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.16

3.46

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

1225

1.35

3.39

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.33

3.36

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

515

1.53

3.28

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

144

1053

1.37

3.27

3.0

2.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

329

1.67

3.25

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

644

5596

1.16

3.17

3.5

3.7

ug/l

13.0

28.2

2.27

519

4651

(3033658) Prothrombin time (PT) actual/Normal

1263

11486

1.12

3.11

3.6

4.0

79.8

81.0

0.98

1220

11203

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

7.47

3.04

1.7

1.5

nmol/l

250.2

217.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

329

2709

1.22

3.00

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

232

1.76

2.98

1.1

1.2

mmol/l

2.1

2.2

0.30

211

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.27

2.89

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.27

2.89

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.27

2.89

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.27

2.89

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.24

2.83

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

600

1.45

2.81

2.7

2.2

mg/l

22.7

29.0

0.34

137

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

422

1.54

2.80

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

186

1.82

2.78

1.5

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

186

1.82

2.78

1.5

2.2

—

(3004775) Volume in Urine collected for unspecified duration

424

1.53

2.75

2.5

2.2

701.3

632.3

0.56

264

(3003181) Sodium [Moles/volume] in Urine

140

1051

1.33

2.74

1.4

1.3

mmol/l

60.7

0.00

114

830

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

628

1.43

2.74

1.2

1.3

e6/l

41.5

28.7

0.14

497

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

628

1.43

2.74

1.3

1.4

e6/l

2356.7

1045.3

0.35

523

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

612

1.44

2.73

1.4

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

630

1.43

2.70

3.8

3.6

iu/ml

958.8

5222.5

0.70

(3044290) Cell count panel - Cerebral spinal fluid

565

1.45

2.67

1.2

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

206

1637

1.26

2.64

1.3

au/ml

77.6

64.5

0.21

(3045414) Leukocytes [Presence] in Urine

222

1782

1.25

2.61

2.4

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

2.20

2.60

1.3

nmol/l

0.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.59

2.56

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

174

1361

1.28

2.55

2.0

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

177

1.80

2.55

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

121

900

1.34

2.54

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

326

2733

1.20

2.52

3.5

2.9

e6/l

0.3

0.4

1.01

313

2685

(3021788) Differential panel - Synovial fluid

113

835

1.35

2.49

1.3

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.10

2.45

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

132

1001

1.32

2.45

2.8

u/ml

395.4

744.7

0.48

114

923

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

552

1.43

2.42

1.3

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

240

1.66

2.42

1.1

1.0

—

(3035880) pH of Pleural fluid

381

1.52

2.42

1.4

1.3

—

(3000492) Spirometry study

316

2653

1.20

2.41

1.4

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

177

1401

1.26

2.38

1.9

1.6

u/l

38.1

38.7

0.14

149

1154

(3000570) Elastase.pancreatic [Mass/mass] in Stool

160

1251

1.28

2.37

1.4

ug/g

283.0

256.9

0.81

786

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

505

1.44

2.37

1.4

1.3

u/l

11.5

13.9

0.72

468

(3006462) Nitrate [Presence] in Urine

219

1.69

2.36

6.9

3.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.40

2.34

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.30

2.28

8.6

9.7

14.2

13.8

0.47

(3047007) Chlamydophila sp Ab [Presence] in Serum

260

1.61

2.27

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

548

4832

1.14

2.25

5.0

5.4

mmol/l

1.3

1.4

1.46

519

4596

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.67

2.25

2.0

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.67

2.25

11.5

14.7

—

(3017569) Oxygen content in Arterial blood

308

1.55

2.24

2.3

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

163

1.77

2.23

1.4

1.3

u/ml

3.8

2.2

0.28

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

127

1.88

2.22

1.5

1.3

umol/l

59.3

78.1

0.55

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

521

1.42

2.21

2.4

u/field

2.4

2.2

0.07

163

(4211845)

239

1.63

2.20

6.6

3.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.18

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

457

1.44

2.16

1.1

u/l

47.4

62.7

2.23

316

(3007566) Smooth muscle Ab [Titer] in Serum

106

799

1.33

2.10

1.2

1.1

titre

188.3

114.4

0.31

(46235355) HIV 1 and 2 tests - Meaningful Use set

341

2923

1.17

2.08

1.5

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

116

1.89

2.07

1.7

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.89

2.05

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

372

1.48

2.05

1.1

mmol/l

33.8

34.3

0.07

292

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

471

1.42

2.04

2.1

1.7

u/ml

29.8

26.9

0.21

109

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

437

4928

0.87

2.03

4.6

4.8

35.0

34.1

0.75

232

3023

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.98

2.03

1.0

1.2

nmol/l

520.8

239.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

307

2619

1.18

2.00

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

1219

1.26

2.00

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

457

1.42

1.99

1.6

1.4

u/l

15.1

13.9

0.69

443

(40768446) Kidney Pathology biopsy report

1.99

1.97

1.6

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

152

1213

1.25

1.96

2.7

2.2

ug/min

115.0

88.4

0.37

704

(44806118)

401

1.44

1.95

1.5

1.3

—

(44790047)

401

1.44

1.95

1.5

1.3

—

(44790048)

401

1.44

1.95

1.5

1.3

—

(44790049)

401

1.44

1.95

1.5

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

120

932

1.29

1.94

1.8

1.5

iu/ml

0.6

12.2

1.11

254

(3021879) Hepatitis B virus core Ab [Presence] in Serum

199

1639

1.22

1.92

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

149

1.74

1.91

1.3

umol/l

15.6

9.1

0.31

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

297

1.51

1.90

2.3

2.1

ug/min

107.4

71.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

106

813

1.30

1.89

2.0

2.2

60.6

59.5

0.19

106

807

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.04

1.88

1.3

3.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.04

1.88

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

364

1.45

1.85

1.2

u/ml

2.3

4.0

0.67

104

(3005570) Glucose [Moles/volume] in Urine

506

1.38

1.85

2.6

2.1

—

(40768800) Prostate Pathology biopsy report

133

1054

1.26

1.84

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

1.84

1.1

1.2

39.2

30.3

0.35

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.08

1.83

3.1

3.0

u/field

0.3

0.6

0.66

(3016330) Potassium [Moles/time] in 24 hour Urine

2.49

1.81

1.1

1.3

—

(3045142) Bone marrow Pathology biopsy report

502

1.37

1.77

1.3

1.2

—

(40768793) Breast Pathology biopsy report

104

805

1.29

1.75

1.4

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

335

2917

1.15

1.71

1.9

1.6

g/l

1.5

1.6

0.61

261

2483

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

313

1.47

1.71

1.1

122.5

113.7

0.77

267

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

421

1.40

1.70

1.3

pmol/l

209.5

253.1

0.97

323

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

132

1.74

1.70

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

543

1.34

1.65

1.3

1.2

u/ml

15.0

48.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

526

1.35

1.65

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.57

1.64

1.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

106

831

1.27

1.64

4.2

3.6

0.9

1.5

1.73

605

(40768441) Liver Pathology biopsy report

219

1.55

1.64

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1324

1.22

1.63

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

292

1.47

1.63

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

407

4537

0.88

1.63

2.4

2.9

kpa

4.3

0.07

391

4352

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

339

2971

1.14

1.60

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

104

817

1.27

1.59

1.2

u/l

70.8

40.5

0.49

693

(4306422)

319

1.44

1.57

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

270

1.48

1.57

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.68

1.57

7.3

3.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

566

1.32

1.55

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

455

1.36

1.54

1.3

mu/l

32.5

59.1

1.74

402

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

222

1891

1.17

1.54

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

951

8830

1.08

1.53

3.3

3.0

e6/l

1.1

1.3

1.68

520

5087

(3023183) Ammonium ion [Moles/volume] in Plasma

111

885

1.25

1.52

1.9

2.0

umol/l

27.9

32.8

1.69

701

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.02

1.52

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

491

1.34

1.51

1.3

1.2

nmol/l

297.7

331.9

0.80

374

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

176

1.59

1.51

5.6

5.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

289

1.45

1.51

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.58

1.50

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

282

1.45

1.48

1.1

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

201

1.54

1.47

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

226

1.50

1.45

1.6

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

410

1.36

1.43

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.91

1.41

1.0

1.5

93.3

80.7

—

(44806420)

212

0.52

1.41

1.8

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

118

1.69

1.38

1.8

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.16

1.38

1.0

—

(21494434) Karyotype in Bone marrow

431

1.34

1.37

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.60

1.36

1.5

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

252

2195

1.15

1.34

1.5

1.6

1.7

0.26

199

1727

(42529406) Shigella sp [Presence] in Stool by Culture

101

1235

0.81

1.31

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

224

1.47

1.30

1.6

1.9

11.4

13.2

0.40

(3034770) Mitochondria Ab [Titer] in Serum

102

823

1.24

1.30

1.2

1.1

titre

1298.0

1169.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

101

1233

0.81

1.29

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.49

1.29

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.29

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

384

1.35

1.29

1.3

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

152

1.57

1.29

1.4

1.3

19.6

24.7

0.48

120

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

419

1.33

1.28

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

134

1115

1.20

1.27

2.4

2.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

569

1.28

1.25

1.8

1.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

438

1.32

1.25

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

194

1.49

1.23

1.2

promille

1.4

1.0

0.68

144

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

101

1225

0.82

1.23

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

480

5208

0.91

1.22

2.2

2.4

ug/l

5.1

6.3

1.80

375

4307

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

388

1.34

1.22

1.3

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.76

1.21

1.0

1.1

umol/24h

0.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.15

1.20

1.4

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

212

1.46

1.19

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

226

1974

1.14

1.19

3.0

2.3

g/l

1.5

1.1

0.42

171

1630

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

393

0.68

1.19

1.0

1.1

iu/ml

1.2

655.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

330

1.36

1.18

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

313

1.37

1.18

9.1

13.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.82

1.17

1.1

1.3

86.0

80.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.82

1.17

1.4

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

213

1.45

1.17

1.1

nmol/l

2.6

15.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

631

0.75

1.15

1.3

nmol/l

1.0

0.8

0.45

510

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.70

1.15

1.3

1.4

—

(4094501)

108

892

1.21

1.13

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

472

1.29

1.13

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

316

1.36

1.13

1.6

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

150

1.53

1.12

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

1.53

1.12

1.2

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

438

1.30

1.11

1.4

1.3

u/ml

122.8

121.0

0.04

(3044941) Cell count panel - Synovial fluid

750

1.22

1.10

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.25

1.10

6.7

4.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

166

1429

1.16

1.09

1.7

1.6

titre

90.9

340.0

2.55

(21494814) CD8 cells/100 lymphocytes in Specimen

127

1.57

1.09

1.7

1.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

398

1.30

1.06

1.2

1.1

u/ml

287.8

308.2

0.18

237

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.11

1.05

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

469

1.28

1.05

1.2

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.95

1.03

1.1

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.78

1.03

7.3

9.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

279

1.36

1.02

2.2

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

271

1.36

1.01

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.73

1.01

1.0

80.4

93.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

349

1.31

1.01

1.2

u/ml

2.7

4.1

1.19

170

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

280

1.35

1.00

1.2

1.1

titre

95.0

130.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

280

1.35

1.00

1.2

1.1

—

126.4

—

(3044640) Blood type and Crossmatch panel - Blood

1500

14349

1.05

1.00

2.6

—

(4268621)

221

1.40

1.00

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

517

1.25

1.00

1.4

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

385

1.29

0.99

1.4

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

412

1.28

0.98

1.6

1.3

titre

201.0

436.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

172

1.45

0.97

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

172

1.45

0.97

1.2

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.80

0.97

29.7

29.2

ug/l

6.3

6.9

0.54

(3006922) Hepatitis E virus Ab [Presence] in Serum

164

1.46

0.96

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

466

1.26

0.96

1.5

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

206

1.40

0.96

1.4

1.2

nmol/l

1.2

1.1

0.22

156

(3045424) Erythrocytes [Presence] in Urine

583

1.23

0.95

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

171

1494

1.14

0.95

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

171

1494

1.14

0.95

1.4

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.68

0.93

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.88

0.93

1.1

1.3

—

(3002032) Base excess in Venous blood by calculation

512

5463

0.93

3.1

3.5

mmol/l

1.6

2.0

1.20

408

4398

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.64

0.92

7.0

9.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

276

1.34

0.92

1.3

1.6

u/l

13.3

6.7

0.58

132

(3004716) Salmonella sp identified in Stool by Organism specific culture

119

1377

0.86

0.92

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.61

0.92

1.1

—

8.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.66

0.90

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

339

1.29

0.89

2.0

1.9

ug/l

2.3

2.1

0.23

285

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.06

0.89

1.2

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.90

0.88

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

2306

1.11

0.88

2.5

2.2

g/l

3.7

3.8

0.31

171

1642

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

428

1.26

0.88

1.1

—

(44813793)

143

1.46

0.87

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

288

1.31

0.86

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

753

0.82

0.84

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

2313

1.11

0.84

2.5

2.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

414

1.25

0.83

1.3

nmol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.56

0.82

1.5

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

2316

1.10

0.82

2.5

2.2

g/l

7.4

7.6

1.53

172

1693

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.73

0.82

1.4

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

212

1900

1.11

0.81

2.1

2.2

ug/l

562.8

594.9

0.08

197

1793

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

274

1.31

0.81

1.2

mmol/l

8.8

7.9

0.62

180

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

318

1.28

0.81

1.5

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

146

1644

0.88

0.80

2.9

3.7

mmol/l

3.9

0.10

116

1512

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

231

1.34

0.80

5.5

4.6

u/ml

246.8

101.6

0.37

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

752

1.18

0.80

1.3

1.2

u/ml

29.3

4.1

0.51

(3021447) Carbon dioxide [Partial pressure] in Venous blood

517

5476

0.93

0.80

3.1

3.4

kpa

5.8

0.29

496

5279

(4027681)

1.54

0.79

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

473

0.78

0.79

1.8

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

125

1086

1.15

0.79

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

224

2018

1.11

0.79

1.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.81

0.78

3.0

3.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

121

0.58

0.77

1.1

1.2

g/l

14.7

15.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1841

1.11

0.77

2.6

2.1

g/l

36.8

36.5

0.27

164

1519

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

645

1.19

0.77

1.2

u/ml

9.6

4.4

0.37

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

509

1.21

0.76

1.4

1.2

—

22.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.58

0.76

1.0

u/ml

0.2

0.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

2194

1.10

0.76

2.5

2.2

g/l

10.5

10.4

0.09

191

1800

(3014271) Vancomycin [Susceptibility]

402

1.24

0.75

2.9

3.2

—

(3006653) Thiamine [Moles/volume] in Blood

174

1.37

0.74

1.1

nmol/l

130.0

133.9

0.22

174

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.07

0.74

1.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

259

2809

0.91

0.74

3.7

4.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.83

0.73

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

760

1.17

0.72

1.3

1.2

u/ml

6.2

5.2

0.16

102

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

182

0.66

0.72

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

108

1.48

0.72

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

320

0.75

0.71

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

239

2175

1.10

0.71

2.0

—

(3042733) HLA Ab [Presence] in Serum

1.74

0.71

3.4

4.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.91

0.70

1.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

809

1.16

0.70

1.3

1.2

u/ml

73.8

37.2

—

(3022689) Creatine [Moles/volume] in Urine

1.57

0.70

1.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

388

1.23

0.70

1.7

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

397

1.23

0.70

1.7

1.3

titre

72.0

46.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

2141

1.10

0.69

2.5

2.2

g/l

3.0

3.2

1.70

173

1664

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

335

1.25

0.69

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

261

0.72

0.68

1.1

—

4.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

1.48

0.68

1.3

nmol/l

140.0

152.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

264

2847

0.92

0.68

2.6

3.3

mmol/l

25.0

25.1

0.19

244

2771

(3019832) Treponema pallidum Ab [Presence] in Serum

719

1.16

0.68

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

900

8595

1.05

0.67

29.2

32.3

inr

1.7

1.6

1.34

1125

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.55

0.67

1.0

1.1

u/ml

0.2

0.8

—

(40761535) Cells panel - Urine sediment

376

3995

0.93

0.66

3.2

3.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.62

0.66

1.0

1.2

—

(3048879) Bone marrow aspiration report

161

1.36

0.66

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

446

1.21

0.65

1.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

847

0.86

0.65

1.4

e6/l

82619.5

59346.9

0.17

501

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

474

1.20

0.65

2.1

3.1

—

(3019225) pH of Specimen

448

4722

0.94

0.63

4.1

4.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.72

0.63

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

206

1.31

0.63

1.3

ug/l

166.0

334.7

0.35

119

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

146

1.36

0.62

3.4

2.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

112

1.42

0.62

1.7

1.4

ug/l

10.0

8.6

0.16

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.59

0.61

6.5

8.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

155

1698

0.91

0.58

3.0

4.1

u/ml

110.9

87.3

0.17

145

1607

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

600

1.16

0.58

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

111

0.63

0.58

1.7

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

114

0.61

0.57

1.1

3.2

—

39.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.71

0.57

1.0

1.1

umol/24h

1.6

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

408

1.20

0.57

1.0

—

(3014891) Appearance of Pleural fluid

140

1.35

0.56

1.6

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

239

2562

0.93

0.56

2.3

2.4

0.7

0.13

229

2467

(3035947) Staphylolysin Ab [Units/volume] in Serum

228

1.27

0.56

1.2

1.1

iu/ml

—

3.3

—

(3052851) Hemolysis interference index of Serum or Plasma

188

1717

1.09

0.56

3.3

3.6

—

(3011412) CD3 cells [#/volume] in Blood

291

1.23

0.56

1.6

1.8

e9/l

1.0

0.12

187

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.55

1.2

u/l

13.0

11.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

117

1044

1.12

0.55

2.1

g/l

3.7

0.00

111

986

(3003434) Protein [Mass/volume] in Pleural fluid

113

1007

1.12

0.54

1.4

1.5

g/l

30.8

30.6

0.04

876

(40765096) Chromosome analysis panel by Banding

122

0.65

0.54

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.57

0.54

1.3

2.3

—

(3024263) Appearance of Synovial fluid

260

0.76

0.54

2.2

1.5

—

(3012441) Differential panel - Pleural fluid

809

0.87

0.53

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.44

0.52

1.6

ug/l

10.3

9.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1054

10812

0.96

0.52

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

0.60

0.51

1.3

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

1.44

0.50

1.4

1.3

mu/l

32.4

83.8

—

(3047189) Immunofixation for 24 hour Urine

259

1.23

0.50

1.4

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

720

0.87

0.50

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

178

0.73

0.49

1.0

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

269

1.22

0.49

1.2

1.5

70.5

68.1

0.16

211

(3036071) Salmonella sp Ab [Titer] in Serum

1.49

0.48

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

631

1.14

0.47

5.2

5.7

mg/l

12.1

12.8

0.60

558

(21494755) Public health laboratory ask at order entry panel

331

0.81

0.47

1.7

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

599

0.86

0.47

3.8

3.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.39

0.47

1.1

—

(3023410) Appearance of Cerebral spinal fluid

276

0.79

0.47

1.1

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

110

992

1.11

0.45

1.8

2.0

89.3

87.6

0.36

940

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

456

1.16

0.45

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

146

1.30

0.45

2.7

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

111

1.35

0.45

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.37

0.43

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

262

0.80

0.43

1.0

1.2

—

786.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

187

1733

1.08

0.43

2.8

2.2

g/l

0.0

0.1

1.21

160

1539

(3022493) Free Hemoglobin [Mass/volume] in Plasma

201

1.24

0.43

1.2

1.5

mg/l

60.5

65.7

0.20

139

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

443

4217

1.05

0.43

2.4

2.3

u/l

35.4

37.5

0.38

350

3542

(3015183) Erythrocyte sedimentation rate

1.45

0.42

1.4

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

104

940

1.10

0.42

1.8

2.1

209.6

215.8

0.28

876

(40768795) Lymph node Pathology biopsy report

394

1.16

0.42

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

113

1.32

0.41

1.6

1.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.41

0.0

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.51

0.41

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.37

0.41

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.40

0.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.40

0.0

4.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

508

1.14

0.40

1.2

1.1

—

(4034850)

143

1316

1.08

0.40

9.7

12.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.40

0.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

240

1.20

0.39

1.7

—

35.6

—

(3008898) HLA-B27 [Presence]

472

1.14

0.39

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.31

0.39

1.1

1.4

umol/l

1.5

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

132

1.28

0.39

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

178

1656

1.07

0.39

3.0

2.7

g/l

0.3

0.01

630

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

889

1.10

0.38

2.0

1.7

mg/l

12.4

12.5

0.05

809

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.40

0.38

1.0

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.38

0.38

2.8

2.5

mg/l

1.9

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.34

0.38

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

202

0.79

0.37

1.0

—

(40757373) Influenza virus identified in Isolate

142

1.26

0.37

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

607

1.12

0.36

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

179

0.78

0.36

2.3

2.5

44.3

37.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

116

1.29

0.36

1.3

1.4

pmol/l

18.9

16.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

116

1.29

0.36

1.3

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

393

0.86

0.35

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

524

1.12

0.35

1.3

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

281

1.17

0.34

1.1

1.2

u/l

22.0

29.8

0.68

228

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

135

1.25

0.34

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

176

1649

1.06

0.33

2.8

2.2

g/l

0.0

0.34

152

1461

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.69

0.33

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

548

0.89

0.33

2.0

1.6

mg/l

1.7

3.6

1.16

420

(4024509)

464

0.88

0.32

1.8

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

154

1.23

0.32

1.2

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

537

1.11

0.32

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

127

1.25

0.32

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.27

0.32

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

310

2956

1.05

0.31

6.9

7.2

mmol/l

24.4

0.06

278

2674

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.34

0.31

1.2

1.3

mg/l

11.4

7.5

—

(4133840)

1.34

0.31

1.7

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

137

1.24

0.31

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.30

0.31

1.2

pmol/l

339.3

264.3

—

(3016879) Cocaine [Presence] in Urine

0.73

0.30

1.3

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

266

1.16

0.30

1.1

—

2.6

—

(3027944) Amphetamines [Presence] in Urine

0.72

0.30

1.3

1.1

—

(3027008) Opiates [Presence] in Urine

0.71

0.30

1.3

1.1

—

(3028300) Cannabinoids [Presence] in Urine

0.70

0.30

1.3

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

530

1.11

0.30

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

183

1.20

0.30

1.3

1.1

u/ml

0.7

0.9

—

(1002224) Polysomnography panel

550

1.10

0.29

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

323

0.86

0.29

3.5

3.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

1.22

0.29

1.1

—

(3034426) Prothrombin time (PT)

1.33

0.29

1.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

138

1.23

0.29

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

138

1.23

0.29

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

172

1620

1.06

0.29

2.8

2.2

g/l

0.0

0.00

152

1455

(3020891) Body temperature

223

2116

1.05

0.29

3.5

4.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

148

1.21

0.28

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

524

1.10

0.28

1.3

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

119

0.75

0.27

1.3

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

526

1.10

0.26

1.3

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

289

1.14

0.26

1.1

1.2

u/l

81.5

102.5

0.99

243

(3045788) Cell count panel - Pleural fluid

709

1.08

0.25

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

527

1.10

0.25

1.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.27

0.25

1.7

1.5

ng/l

98.5

128.8

0.58

(3038026) Centromere Ab [Units/volume] in Serum

286

0.87

0.25

1.1

—

93.2

—

(4281824)

443

0.90

0.25

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

141

1.20

0.25

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.19

0.24

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

395

1.11

0.24

1.1

g/l

1.4

1.6

2.05

353

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

123

1.21

0.24

1.4

1.6

3.7

6.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

151

1.19

0.24

1.1

1.2

g/l

46.9

38.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

253

0.86

0.23

8.1

3.1

—

(3025315) Body weight

1.34

0.23

7.4

5.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.28

0.23

1.1

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

242

0.86

0.23

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.31

0.23

1.2

1.3

—

(4146454)

502

0.91

0.22

2.5

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.24

0.22

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

0.85

0.22

1.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.21

0.22

1.4

1.2

ng/l

26.4

163.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

911

0.94

0.21

1.4

e6/l

1220.7

1820.8

0.97

639

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.21

0.0

2.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

2340.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

166

0.84

0.21

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

3.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

390

1.10

0.21

1.2

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.20

0.0

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.0

—

(40763791) Oxygen content in Venous blood by calculation

0.00

0.20

0.0

2.4

—

11.8

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.20

0.0

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

355.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

186

0.86

0.20

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

145

1.17

0.19

2.1

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

121

1148

1.05

0.19

1.5

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

185

1774

1.04

0.18

4.1

4.2

mmol/l

24.6

24.9

0.61

157

1566

(3000475) Leukocytes [#/volume] in Synovial fluid

116

1102

1.05

0.17

1.4

1.5

e6/l

16066.0

16336.5

0.02

775

(40768806) Pleura Pathology biopsy report

782

1.06

0.17

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

256

0.89

0.17

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.77

0.17

1.6

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.75

0.17

1.4

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

276

0.90

0.16

1.8

2.3

—

(3000285) Sodium [Moles/volume] in Blood

1.21

0.16

1.6

1.1

—

(4010399)

269

2610

1.03

0.15

1.4

—

(3020491) Glucose [Moles/volume] in Blood

305

0.91

0.15

2.2

2.7

mmol/l

6.9

7.2

0.41

217

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

149

1.14

0.14

1.2

1.7

e6/l

7262.8

20327.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.82

0.14

1.3

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.81

0.14

3.0

2.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

216

1.11

0.14

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

216

1.11

0.14

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

409

1.07

0.14

1.1

1.3

e6/l

396604.0

179053.8

0.40

278

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.10

0.13

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.10

0.13

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.10

0.13

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

241

0.91

0.13

1.1

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

266

1.09

0.12

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

266

1.09

0.12

1.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1027

10319

0.99

0.12

3.9

4.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

218

1.10

0.12

1.1

—

(3022313) Gas panel - Capillary blood

226

2197

1.02

0.12

3.7

3.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

161

1.11

0.12

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

186

1896

0.98

0.11

3.2

2.9

u/ml

3833.8

3653.3

0.02

168

1580

(3023487) Leukocytes [#/volume] in Peritoneal fluid

162

1.11

0.11

1.2

1.8

e6/l

665.4

4691.9

—

111

(40758558) Short blood count panel - Blood

1091

10767

1.01

0.10

5.8

6.2

—

(3000034) Microalbumin [Mass/volume] in Urine

366

1.06

0.10

2.9

3.2

mg/l

75.9

39.1

0.46

276

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.16

0.10

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.16

0.10

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.16

0.10

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

708

1.04

0.10

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

145

0.89

0.10

1.4

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

145

0.89

0.10

1.9

2.0

umol/l

68.6

56.2

—

105

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.13

0.09

1.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

135

1.11

0.09

1.3

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

1.14

0.09

1.2

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

496

1.04

0.08

3.9

3.5

umol/l

313.9

320.2

0.10

392

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.83

0.08

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

199

1944

1.02

0.08

2.7

3.5

mmol/l

1.5

0.01

194

1908

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.78

0.08

1.6

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

155

1.09

0.08

1.3

1.1

—

(3000991) Gas panel - Venous blood

458

4606

0.99

0.08

6.3

6.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

350

1.05

0.08

1.5

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

350

1.05

0.08

1.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

350

1.05

0.08

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

280

2746

1.02

0.08

3.5

3.6

mmol/l

24.1

0.01

249

2460

(4015189)

107

1.12

0.08

2.8

2.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.05

0.07

13.1

13.6

mmol/l

4.1

5.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.03

0.07

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.12

0.07

1.1

—

(3036603) Volume of Urine

283

1.05

0.07

1.5

1.6

1963.3

1741.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

340

3345

1.01

0.06

2.6

3.1

g/l

125.1

125.5

0.16

325

3274

(3013727) Leukocytes other/100 leukocytes in Blood

182

0.93

0.06

9.0

3.4

49.5

55.3

0.35

175

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

394

1.04

0.05

1.4

—

(3033799) Differential panel - Peritoneal fluid

160

0.93

0.05

1.3

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

169

1.06

0.04

2.0

2.2

—

(3036489) Thrombin time

143

1405

1.01

0.04

1.6

1.8

21.5

21.8

0.45

123

1276

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

980

0.98

0.03

1.3

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

208

0.96

0.03

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

238

0.96

0.03

1.3

1.8

—

69.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

508

0.98

0.02

5.7

4.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

369

1.02

0.02

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

497

0.98

0.02

3.7

3.6

57.5

59.8

0.24

276

(3028433) Virus identified in Specimen by Culture

122

1.06

0.02

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

229

2290

0.99

0.01

2.6

2.5

u/ml

0.3

0.4

0.11

130

1296

(3014576) Chloride [Moles/volume] in Serum or Plasma

674

6716

1.00

0.01

5.4

5.9

mmol/l

104.1

104.2

0.28

632

6549

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

263

1.02

0.00

1.1

1.0

ng/l

267.4

335.1

1.65

158

(3010726) Horse dander IgE Ab [Units/volume] in Serum

109

1.00

0.00

1.0

u/ml

0.0

0.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

103

0.97

0.00

1.1

1.4

umol/l

28.1

28.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

264

1.02

0.00

1.1

1.0

ng/l

31.3

47.1

2.97

158

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

293

0.98

0.00

2.4

—

(3002619) Bacteria identified in Specimen by Culture

111

0.99

0.00

1.3

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

293

1.02

0.00

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

293

1.02

0.00

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

135

1.03

0.00

2.4

1.9

u/l

22.1

58.3

1.16

127

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

265

1.01

0.00

1.1

1.0

ng/l

715.4

613.4

0.42

154

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

107

1.02

0.00

1.0

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

104

1.05

0.00

1.4

1.5

ug/l

0.3

0.4

—

(3003129) Base excess in Capillary blood by calculation

119

1.00

0.00

1.9

2.0

mmol/l

-0.3

1.1

0.78

105

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

163

0.98

0.00

1.6

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

163

0.98

0.00

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

216

1.01

0.00

1.5

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

216

1.01

0.00

1.5

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

216

1.01

0.00

1.5

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

216

1.01

0.00

1.5

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

323

1.02

0.00

1.2

nmol/l

1.6

1.4

0.27

285

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

164

1.03

0.00

1.6

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

113

0.97

0.00

1.1

—

552.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

116

1.03

0.00

1.2

—

(3025130) Human papilloma virus identified in Specimen

175

1.02

0.00

1.6

1.7

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.92

0.00

1.2

1.1

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

6.2

—

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

0.2

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.5

—

13.7

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

47.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.99

0.00

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

331.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.7

—

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.84

0.00

1.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

9.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.3

—

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.99

0.00

1.0

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011288) Drugs identified in Urine by Screen method

0.88

0.00

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.99

0.00

1.3

1.4

umol/l

44.3

43.3

—

(3020650) Glucose [Presence] in Urine

0.99

0.00

1.8

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.91

0.00

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

1.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_PRESBY and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_PRESBY	0.901 [0.83, 0.98]	0.013
Birth year	0.994 [0.99, 1.0]	0.113

During the follow-up period (1.1.1998 — 31.12.2019), 17982 out of 34767 females with H8_HL_PRESBY died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_PRESBY	0.939 [0.85, 1.03]	0.19
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 12373 out of 23536 males with H8_HL_PRESBY died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_PRESBY.

N-year risk	Females	Males
1	0.082%	0.164%
5	0.533%	1.051%
10	1.268%	2.716%
15	2.457%	5.224%
20	4.262%	8.789%

Relationships between endpoints

↥

Index endpoint: H8_HL_PRESBY – Presbycusis

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Presbycusis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints